Financial Snapshot

Revenue
$0.00
TTM
Gross Margin
Net Earnings
-$29.64M
TTM
Current Assets
$69.79M
Q3 2024
Current Liabilities
$6.349M
Q3 2024
Current Ratio
1099.15%
Q3 2024
Total Assets
$90.73M
Q3 2024
Total Liabilities
$21.33M
Q3 2024
Book Value
$69.40M
Q3 2024
Cash
$5.526M
Q3 2024
P/E
-7.078
Nov 29, 2024 EST
Free Cash Flow
-$26.77M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019
Revenue $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019
Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Cost Of Revenue
Gross Profit
Gross Profit Margin

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019
Selling, General & Admin $9.256M $11.25M $2.343M $1.700M $1.374M
YoY Change -17.7% 379.98% 37.82% 23.73%
% of Gross Profit
Research & Development $26.42M $20.89M $11.45M $7.544M $6.636M
YoY Change 26.49% 82.49% 51.74% 13.68%
% of Gross Profit
Depreciation & Amortization $1.074M $979.0K $776.0K $86.00K $66.00K
YoY Change 9.7% 26.16% 802.33% 30.3%
% of Gross Profit
Operating Expenses $35.68M $32.14M $13.79M $1.370K $8.010M
YoY Change 11.03% 133.04% 1006469.34% -99.98%
Operating Profit -$35.68M -$32.14M -$13.79M -$9.244M
YoY Change 11.03% 133.04% 49.18%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019
Interest Expense $4.545M $2.203M -$201.0K $714.0K $697.0K
YoY Change 106.31% -1196.02% -128.15% 2.44%
% of Operating Profit
Other Income/Expense, Net $1.994M $16.55K -$13.27M -$194.0K -$1.005M
YoY Change 11950.52% -100.12% 6741.75% -80.7%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019
Pretax Income -$29.14M -$33.74M -$27.26M -$1.370K -$8.318M
YoY Change -13.64% 23.76% 1989972.99% -99.98%
Income Tax $16.00K $20.00K $7.000K $158.0K $146.0K
% Of Pretax Income
Net Earnings -$29.16M -$33.76M -$27.27M -$1.370K -$8.367M
YoY Change -13.64% 23.8% 1990483.94% -99.98%
Net Earnings / Revenue
Basic Earnings Per Share -$0.42 -$0.53 -$0.67 -$0.22
Diluted Earnings Per Share -$0.42 -$0.53 -$398.2K -$39.85 -$122.2K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019
Cash & Short-Term Investments $81.79M $104.5M $31.32M $46.02M $28.13M
YoY Change -21.76% 233.79% -31.94% 63.59%
Cash & Equivalents $12.66M $5.836M $23.24M $15.60M $1.831M
Short-Term Investments $69.13M $98.69M $8.080M $30.42M $26.30M
Other Short-Term Assets $3.949M $1.915M $1.303M $165.0K $1.134M
YoY Change 106.21% 46.97% 689.55% -85.45%
Inventory
Prepaid Expenses
Receivables $0.00 $541.0K
Other Receivables $5.000K $23.00K
Total Short-Term Assets $85.76M $106.5M $32.64M $165.0K $29.83M
YoY Change -19.46% 226.21% 19678.83% -99.45%
Property, Plant & Equipment $21.16M $13.28M $7.546M $5.395M $1.714M
YoY Change 59.33% 76.0% 39.87% 214.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $471.0K $391.0K $2.028M $139.0K $16.00K
YoY Change 20.46% -80.72% 1358.99% 768.75%
Total Long-Term Assets $21.63M $13.67M $9.574M $0.00 $1.730M
YoY Change 58.22% 42.8% -100.0%
Total Assets $107.4M $120.1M $42.22M $165.0K $31.56M
YoY Change
Accounts Payable $2.566M $1.423M $1.251M $1.012M $893.0K
YoY Change 80.32% 13.75% 23.62% 13.33%
Accrued Expenses $4.457M $2.852M $3.154M $51.55K $456.0K
YoY Change 56.28% -9.58% 6018.33% -88.7%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $89.85K $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.102M $4.338M $4.405M $141.4K $1.349M
YoY Change 63.72% -1.52% 3015.28% -89.52%
Long-Term Debt $5.610M $0.00 $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $10.20M $10.15M $18.62M $5.366M $5.163M
YoY Change 0.46% -45.48% 247.06% 3.93%
Total Long-Term Liabilities $15.81M $10.15M $18.62M $0.00 $5.163M
YoY Change 55.71% -45.48% -100.0%
Total Liabilities $22.91M $14.49M $23.03M $141.4K $6.512M
YoY Change 58.11% -37.07% 16185.71% -97.83%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019
Basic Shares Outstanding 69.38M shares 63.53M shares 40.53M shares 40.27M shares
Diluted Shares Outstanding 69.38M shares 63.53M shares 40.53M shares 40.27M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $209.77 Million

About Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The firm has one subsidiary Healthcare Capital Corp.

Industry: Surgical & Medical Instruments & Apparatus Peers: InMode Ltd. Nano-X Imaging Ltd.